Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer

Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 6, 2006, Pages 858-864

  Keum, Ki Chang ^a   Chung, Eun Ji ^c   Koom, Woong Sub ^a   Cho, Jae Ho ^a   Cho, Sang Ho ^b   Choi, Eun Chang ^b   Lee, Chang Geol ^a   Suh, Chang Ok ^a   Kim, Gwi Eon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLINE; PROTEIN P53;

ADULT; ARTICLE; CANCER PATIENT; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK METASTASIS; OCCULT CANCER; PREDICTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE SECTION; TONGUE CANCER; TUMOR DIFFERENTIATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33751436195     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.02.011     Document Type: Article

References (20)

1. Woolgar J.A., Rogers S.N., Lowe D., et al. Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol 39 (2003) 130-137
2. Lopes M.A., Nikitakis N.G., Reynolds M.A., et al. Biomarkers predictive of lymph node metastases in oral squamous cell carcinoma. J Oral Maxillofac Surg 60 (2002) 142-147
3. Sidari L., Tirelli G., Papanikolla L., et al. Flow cytometry expression of p53 and PCNA in oral/oropharynx carcinomas and their lymph node metastases. Anticancer Res 23 (2003) 4127-4132
4. Woods D.B., and Vousden K.H. Regulation of p53 function. Exp Cell Res 264 (2001) 56-66
5. Vielba R., Bilbao J., Ispizua A., et al. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113 (2003) 167-172
6. Chiba I., Shindoh M., Yasuda M., et al. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 12 (1996) 1663-1668
7. Narayana A., Vaughan A.T., Kathuria S., et al. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 46 (2000) 21-26
8. Obata A., Eura M., Sasaki J., et al. Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. Int J Cancer 89 (2000) 187-193
9. Sommer T., and Olofsson J. Significance of p53, PCNA and Ki-67 in the prognosis of squamous cell carcinoma of the oral cavity. Laryngorhinootologie 76 (1997) 189-196
10. Ahomadegbe J.C., Barrois M., Fogel S., et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10 (1995) 1217-1227
11. Leedy D.A., Trune D.R., Kronz J.D., et al. Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg 111 (1994) 417-422
12. Staibano S., Mignogna M.D., Lo Muzio L., et al. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol 29 (1998) 1189-1194
13. Franchi A., Gallo O., Boddi V., et al. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 2 (1996) 1801-1808
14. Chen R.B., Suzuki K., Nomura T., et al. Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymph node metastasis. J Oral Maillofac Surg 51 (1993) 397-401
15. Rubio Bueno P., Naval Gias L., Garcia Delgado R., et al. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head Neck 20 (1998) 232-239
16. Kastan M.B., Onyekwere O., Sidransky D., et al. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51 (1991) 6304-6311
17. Mahmood J.U., Suzuki K., Nomura T., et al. The implication of DNA content and S-phase fraction in oral carcinomas with and without metastasis. Int J Oral Maillofac Surg 24 (1995) 427-432
18. Liu M., Lawson G., Delos M., et al. Prognostic value of cell proliferation markers, tumor suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol 260 (2003) 28-34
19. Sakai E., and Tsuchida E. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 7 (1992) 927-933
20. Mercer W.E., Shields M.T., Lin D., et al. Growth suppression induced by wild type p53 protein is accompanied by selective down-regulation of proliferating cell nuclear antigen expression. Proc Natl Acad Sci U S A 88 (1991) 1958-1962